Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries (Q38355133)

2 September 2017

1 reference

title

Burden of asthma and chronic obstructive pulmonary disease and access to essential medicines in low-income and middle-income countries (English)

1 reference

chronic obstructive pulmonary disease

2 September 2017

0 references

1 reference

David Beran

1

0 references

author name string

Heather J Zar

2

1 reference

2 September 2017

Christophe Perrin

3

1 reference

2 September 2017

Ana M Menezes

4

1 reference

2 September 2017

Peter Burney

5

1 reference

2 September 2017

Forum of International Respiratory Societies working group collaboration

6

1 reference

2 September 2017

language of work or name

1 reference

1 February 2015

1 reference

The Lancet. Respiratory medicine

2 September 2017

published in

1 reference

2 September 2017

volume

3

1 reference

2 September 2017

issue

2

1 reference

2 September 2017

page(s)

159-170

1 reference

The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three: a global synthesis

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Prevalence of symptoms of asthma, rhinitis and eczema in 13- to 14-year-old children in Africa: the International Study of Asthma and Allergies in Childhood Phase III.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

The relationship of per capita gross national product to the prevalence of symptoms of asthma and other atopic diseases in children (ISAAC)

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Which population level environmental factors are associated with asthma, rhinoconjunctivitis and eczema? Review of the ecological analyses of ISAAC Phase One.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Regional variation in asthma symptom prevalence in Latin American children

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Prevalence of asthma: a comparative study of urban and rural Xhosa children

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Comparison of the prevalence of reversible airways obstruction in rural and urban Zimbabwean children

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Exercise induced bronchospasm in Ghana: differences in prevalence between urban and rural schoolchildren

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Bronchial hyper-responsiveness and atopy in urban, peri-urban and rural South African children

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Effect of body mass on exercise-induced bronchospasm and atopy in African children

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Global variation in the prevalence and severity of asthma symptoms: phase three of the International Study of Asthma and Allergies in Childhood (ISAAC).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Atopy, asthma, and antibodies to Ascaris among rural and urban children in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Urban/rural differences in diet and atopy in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

National income, self-reported wheezing and asthma diagnosis from the World Health Survey

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Respiratory abnormalities in Papua New Guinea children: the effects of locality and domestic wood smoke pollution

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty--a BOLD analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Summarising published results from spirometric surveys of COPD: the problem of inconsistent definitions

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Risk factors for COPD spirometrically defined from the lower limit of normal in the BOLD project

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Prevalence and correlates of airflow obstruction in ∼317,000 never-smokers in China

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Tuberculosis and airflow obstruction: evidence from the PLATINO study in Latin America

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

A systematic review of the association between pulmonary tuberculosis and the development of chronic airflow obstruction in adults

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

An integrated risk function for estimating the global burden of disease attributable to ambient fine particulate matter exposure

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Prevalence of COPD in India: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

The burden of COPD in Africa: a literature review and prospective survey of the availability of spirometry for COPD diagnosis in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Forced vital capacity, airway obstruction and survival in a general population sample from the USA.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Association of reduced total lung capacity with mortality and use of health services.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Relation of fetal growth to adult lung function in south India

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Low birth weight and lung function in adulthood: retrospective cohort study in China, 1948-1996.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Heritability of pulmonary function estimated from pedigree and whole-genome markers

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

The use of ethnically specific norms for ventilatory function in African-American and white populations

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Case-finding options for COPD: results from the Burden of Obstructive Lung Disease study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Cost effectiveness of strategies to combat chronic obstructive pulmonary disease and asthma in sub-Saharan Africa and South East Asia: mathematical modelling study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Gaps in capacity in primary care in low-resource settings for implementation of essential noncommunicable disease interventions

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Home-made spacers for bronchodilator therapy in children with acute asthma: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Commercial versus home-made spacers in delivering bronchodilator therapy for acute therapy in children

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Is the Brazilian pharmaceutical policy ensuring population access to essential medicines?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Essential medicines for COPD and asthma in low and middle-income countries

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Measuring the affordability of medicines: importance and challenges.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Quantifying the impoverishing effects of purchasing medicines: a cross-country comparison of the affordability of medicines in the developing world

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Support for smoke-free policy, and awareness of tobacco health effects and use of smoking cessation therapy in a developing country

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

The global research neglect of unassisted smoking cessation: causes and consequences

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Improving global access to medicines for non-communicable diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Access to inhaled corticosteroids is key to improving quality of care for asthma in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Management of chronic disease by patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

The GINA Asthma Challenge: reducing asthma hospitalisations

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

Overcoming health-systems constraints to achieve the Millennium Development Goals.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2815%2900004-1

7 January 2021

10.1016/S2213-2600(15)00004-1

Identifiers

DOI

1 reference

release_fewqywd76zhxlf6aoqlo5rw6f4

2 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/fewqywd76zhxlf6aoqlo5rw6f4

24 November 2022

mapped directly with Wikidata item

1 reference